Dexketoprofen
MUSCULO-SKELETAL SYSTEM
Also known as: (+)-Ketoprofen, (S)-Ketoprofen, dexketoprofen trometamol
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Dexketoprofen is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including PTGS1 and PTGS2.
- Molecular targets: PTGS1 and PTGS2 (2 listed in DrugCentral).
- ATC code: M01AE17 (Propionic acid derivatives).
- Molecular formula: C16H14O3; molecular weight 254.28 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | PTGS1 | inhibitor | IC50 8.72 |
| Prostaglandin G/H synthase 2 | PTGS2 | inhibitor | IC50 7.57 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
M01AE17 | MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS › Propionic acid derivatives |
M02AA27 | MUSCULO-SKELETAL SYSTEM › TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN › TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN › Antiinflammatory preparations, non-steroids for topical use |
N02AJ14 | NERVOUS SYSTEM › ANALGESICS › OPIOIDS › Opioids in combination with non-opioid analgesics |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Acute kidney injury | 132.5 |
| Tubulointerstitial nephritis | 115.0 |
| Hyperaesthesia | 105.5 |
| Drug interaction | 93.9 |
| Polyneuropathy in malignant disease | 93.9 |
| Quality of life decreased | 87.8 |
| Pancreatic failure | 76.2 |
| Angioedema | 75.8 |
| Hyperbilirubinaemia | 75.6 |
| Allodynia | 69.4 |
| Hepatic cytolysis | 68.1 |
| Coagulopathy | 63.5 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Dexketoprofen is on its molecule page.
| Molecular formula | C16H14O3 |
|---|---|
| Molecular weight | 254.28 g/mol |
| CAS number | 22161-81-5 |
| InChIKey | DKYWVDODHFEZIM-NSHDSACASA-N |
| PubChem CID | 667550 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Dexketoprofen work?
Its molecular targets in DrugCentral include PTGS1 (inhibitor) and PTGS2 (inhibitor).
What is the chemical formula of Dexketoprofen?
Dexketoprofen has the molecular formula C16H14O3 and a molecular weight of 254.28 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 833 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL75435 — compound record and bioactivity
- PubChem CID 667550 — chemical identifiers
- DrugBank DB09214 — drug record
- FDA UNII 6KD9E78X68 — substance identity
- UniProt P23219 (PTGS1) — target protein
- UniProt P35354 (PTGS2) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.